Vaxcyte, Inc. (PCVX) Misses Q4 EPS by 77c

Vaxcyte, Inc. (NASDAQ: PCVX) reported Q4 EPS of ($1.82), $0.77 worse than the analyst estimate of ($1.05).

For earnings history and earnings-related data on Vaxcyte, Inc. (PCVX) click here.

You May Also Be Interested In

• Oracle (ORCL) Tops Q1 EPS by 19c, Beats on Revenue; Beats on Cloud Revenue, Offers Q3 EPS Guidance
• Champions Oncology (CSBR) Tops Q1 EPS by 6c
• Jefferies conference highlights mining sector optimism on copper